AltheaDx Obtains $7,249,849 New Financing Round

  • Feed Type
  • Date
    6/27/2013
  • Company Name
    AltheaDx
  • Mailing Address
    3550 Dunhill Street San Diego, CA 92121
  • Company Description
    Our proprietary gene expression profiles include assays for differential diagnosis of pediatric cancers and for improved diagnosis and management of prostate cancer. We have a track record of reducing the time, risk, and cost of drug development by providing biomarker discovery and development to biopharma clients and clinical testing services to physicians.
  • Website
    http://www.altheadx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $7,249,849
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.